Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide in Overweight or Obese Adults: A Systematic Review with Meta-Analysis.

Gilson DornelesEllen AlgeriGerhard LauterbachMarcelo PereiraBrigida Fernandes

Published in: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association (2024)

This up-to-date systematic review highlights that once-weekly semaglutide treatment resulted in clinically important weight loss, becoming a promising adjuvant therapy for obesity.

Keyphrases

weight loss
systematic review
bariatric surgery
roux en y gastric bypass
gastric bypass
weight gain
meta analyses
metabolic syndrome
early stage
glycemic control
obese patients
type diabetes
insulin resistance
adipose tissue
randomized controlled trial
combination therapy
skeletal muscle